Bernd Baumann
- Cancer Research top 0.5%
- NF-κB Signaling Pathways 30
- Oncology top 2%
- Immunology top 2%
- Immune Response and Inflammation 13
- Molecular Biology top 2%
- Cell death mechanisms and regulation 13
- Genomics, phytochemicals, and oxidative stress 4
- RNA regulation and disease 4
- Neurology top 2%
- Neuroinflammation and Neurodegeneration Mechanisms 8
-
- Orthopaedic implants and arthroplasty 11
- Orthopedic Infections and Treatments 9
- Co-authors
- Thomas WirthNinel AzoiteiHubert PehambergerNorbert KrautHartmut BeugAndreas SommerStefan GrünertMargit A. Huber
- Cited by
- Cancer ResearchOncologyImmunology
- Journals
- Journal of Biological Chemistry (5 papers)Blood (4 papers)Journal of Clinical Investigation (3 papers)
- Partner nations
- GermanyUnited StatesUnited Kingdom
In The Last Decade
Bernd Baumann
83 papers receiving 5.7k citations
Hit Papers
Peers
Comparison fields: 5 of 125
- Cancer Research 1.7k
- Oncology 1.5k
- Immunology 1.2k
- Molecular Biology 3.1k
- Neurology 337
Countries citing papers authored by Bernd Baumann
This map shows the geographic impact of Bernd Baumann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bernd Baumann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bernd Baumann more than expected).
Fields of papers citing papers by Bernd Baumann
This network shows the impact of papers produced by Bernd Baumann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bernd Baumann. The network helps show where Bernd Baumann may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Bernd Baumann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 9 | |
| 3 | 2023 | 11 | |
| 4 | 2022 | 7 | |
| 5 | 2021 | 10 | |
| 6 | 2020 | 24 | |
| 7 | 2017 | 28 | |
| 8 | 2013 | 58 | |
| 9 | 2013 | 62 | |
| 10 | 2010 | 169 | |
| 11 | 2010 | 53 | |
| 12 | 2007 | 149 | |
| 13 | 2007 | 40 | |
| 14 | 2006 | 36 | |
| 15 | NF-κB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progressionbreakdown → | 2004 | 734 |
| 16 | 2003 | 3 | |
| 17 | 2003 | 49 | |
| 18 | 2002 | 73 | |
| 19 | 1999 | 125 | |
| 20 | 1995 | 36 |
About Bernd Baumann
Bernd Baumann is a scholar working on Cancer Research, Neurology, Immunology, Molecular Biology and Aging, having authored 84 papers that have together received 5.7k indexed citations. Recurring topics across this work include NF-κB Signaling Pathways (30 papers), Cell death mechanisms and regulation (13 papers), Immune Response and Inflammation (13 papers), Orthopaedic implants and arthroplasty (11 papers), Orthopedic Infections and Treatments (9 papers), Neuroinflammation and Neurodegeneration Mechanisms (8 papers), Genomics, phytochemicals, and oxidative stress (4 papers) and RNA regulation and disease (4 papers). The work is most often cited by research in Cancer Research (1.7k citations), Oncology (1.5k citations), Immunology (1.2k citations), Molecular Biology (3.1k citations) and Neurology (337 citations). Bernd Baumann has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Thomas Wirth, Ninel Azoitei, Hubert Pehamberger, Norbert Kraut, Hartmut Beug, Andreas Sommer, Stefan Grünert, Margit A. Huber, Klaus‐Michael Debatin and Ingrid Herr. Their work appears in journals such as Journal of Biological Chemistry, Blood, Journal of Clinical Investigation, Journal of Neuroscience and The FASEB Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.